One of the most promising therapeutic targets for cerebral edema is the sulfonylurea receptor 1-immediate receptor potential melatonin 4 (SUR1-TRPM4) channel, which is upregulated in response to ischemic injury and contributes to cytotoxic edema [109]. This evidence concerns the gene ABCC8 and brain edema.